LA JOLLA, Calif., January 5, 2008 Scientists at Burnham Institute for Medical Research have demonstrated important new roles for the protein kinase complex Cdc7/Dbf4 or Cdc7/Drf1 (Ddk) in monitoring damage control during DNA replication and reinitiating replication following DNA repair. Since Ddk is often deregulated in human cancers, this new understanding of its role in DNA damage control could help shape new cancer therapies.
Sedat Büyükdemirci: Worldwide PHARMA News is out! http://t.co/8fb4OkiM1M Stories via @flabiotechnews @BerndNiklas
Scott Vogelsberg: Many thanks to @flabiotechnews @andreawork @MedicalSEA @IBT_Bioservices @yazattorney for RTs/mentions this week (2)
Florida Biotech: Contributed Tweets for @flabiotechnews are delivered by @RoundTeam https://t.co/16awq1CIP2
Find us on Google+